Treatment options for relapsed acute promyelocytic leukaemia
- 22 August 2003
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 16 (3) , 521-534
- https://doi.org/10.1016/s1521-6926(03)00039-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemiaBlood, 2001
- United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaJournal of Clinical Oncology, 2001
- Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxideBlood, 2001
- Torsades de pointes in 3 patients with leukemia treated with arsenic trioxideBlood, 2001
- Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia PatientsBlood, 1999
- Therapy of Molecular Relapse in Acute Promyelocytic LeukemiaBlood, 1999
- Molecular Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Acute Promyelocytic LeukemiaBlood, 1999
- Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC TrialBlood, 1999
- Early Detection of Relapse by Prospective Reverse Transcriptase-Polymerase Chain Reaction Analysis of the PML/RARα Fusion Gene in Patients With Acute Promyelocytic Leukemia Enrolled in the GIMEMA-AIEOP Multicenter “AIDA” TrialBlood, 1998
- Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia CellsJNCI Journal of the National Cancer Institute, 1998